Structure Activity Relationship of Key Heterocyclic Anti-Angiogenic Leads of Promising Potential in the Fight against Cancer

Pathological angiogenesis is a hallmark of cancer; accordingly, a number of anticancer FDA-approved drugs act by inhibiting angiogenesis via different mechanisms. However, the development process of the most potent anti-angiogenics has met various hurdles including redundancy, multiplicity, and deve...

Descripción completa

Detalles Bibliográficos
Autores principales: Nada, Hossam, Elkamhawy, Ahmed, Lee, Kyeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865909/
https://www.ncbi.nlm.nih.gov/pubmed/33494492
http://dx.doi.org/10.3390/molecules26030553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865909/
https://www.ncbi.nlm.nih.gov/pubmed/33494492
http://dx.doi.org/10.3390/molecules26030553

Ejemplares similares